A delayed mathematical model of Dengue dynamical transmission between vector mosquitoes and human, incorporating a control strategy of perfect pediatric vaccination is proposed in this paper. By some analytical skills, we obtain the existence of disease-free equilibria and endemic equilibrium, the necessary conditions of global asymptotical stability about two disease-free equilibria. Further, by Pontryagin's maximum principle, we obtain the optimal control of the disease. Finally, numerical simulations are carried out to verify the correctness of the theoretical results and feasibility of the control measure.
Introduction
Dengue fever and dengue hemorrhagic fever are the vector-borne diseases which transcend international borders as the most important arboviral diseases currently threatening human populations. The research found that more than approximately 50 million people are affected by dengue disease each year [1] . The virus of dengue is transmitted to humans by mosquitoes, mostly the Aedes aegypti and Aedes albopictus. There are at least four different serotypes of dengue viruses, therefore people might be infected with dengue disease more than once [2] . Up to present, the only available strategy against dengue still controls the vectors. Despite combined community participation with vector control, together with active disease surveillance and insecticides, whereas, the example of successful dengue prevention and control on a national scale are little. Besides, in the wake of the level of resistance of Aedes aegypti and Aedes albopictus to insecti-cides increasing, the intervals between treatments are shorter, moreover, as a result of the high costs for development and registration and low returns, only few insecticide products are available in the markets [3] . Considering these conditions, vaccination could be more effectiveness and security to protect dengue viruses.
In 1760, the Swiss mathematician Daniel Bernoulli published an investigation on the impact of immunization with cowpox. From then on, the means of protecting figures from infection through immunization begin to be widely used; in addition, the method has already successfully decreased both mortality and morbidity [4] . Based on data from WHO, the worldwide majority of patients suffering from Dengue fever are children. Meanwhile, immunization could be including a category, i.e., pediatric vaccination.
There are a lot of pediatric vaccines have already protected multiple childhood diseases successfully, such as Calmette's vaccine, hepatitis B vaccine and measles vaccine, etc. In view of the fact that many childhood diseases have very low immunity-loss rate, considering the conditions of perfect pediatric vaccination are reasonable.
Since the 1940s, dengue vaccines have been under development. But industry interest languished throughout the 20th century owing to the limited appreciation of global disease burden and the potential markets for it. In recent years, however, with the increase in dengue infections, the development of dengue vaccines has amazingly accelerated, as well as the prevalence of all four circulating serotypes. It became a serious concern for faster development of a vaccine [5] . To guide public support for vaccine development in both industrialized and developing countries, economic analysis are conducted, including previous cost-effectiveness study of dengue [6] [7] . The cost of the disease burden with possibility of making a vaccination campaign are compared by the authors of these analytical works; when compared two situations, they consider that the way of dengue intervention-dengue vaccines has a potential economic benefit.
On the other hand, there are three successive aquatic juvenile phases (egg, larva and pupa) and one adult pupa for the life cycle of the mosquitoes. It is large compared the duration from the egg to the adult (1 -2 weeks) with the average life span (about 3 weeks) of an adult mosquito. The size of the mosquito population is strongly affected by temperature. The number of female mosquitoes changes accordingly due to seasonal variations. When the size of the mosquito population increases during the favorable periods, the dengue virus infection among individuals also increases, therefore the incidence for humans' increases. Then it is vital to consider the maturation time of mosquitoes, the length of the larval phase from egg to adult mosquitoes, and the impact on the transmission of dengue virus.
Based on above-mentioned conditions, a dengue dynamical model with maturation delay and pediatric vaccination is proposed to consider the effects of maturation delay and pediatric vaccination for the transmission of dengue between mosquitoes and human. The remaining parts of this paper are organized as follows. A form of vaccination model is formulated: a perfect pediatric vaccination model, in the next Section. And the stability of equilibria of the model is analysed in Section 3. In Section 4, the optimal control strategy of the disease is discussed. Finally, the numerical simulation is performed in Section 5.
Model Formulation and Preliminaries
Dengue can be a serious candidate for a type of vaccination which is much focus on vaccinating newborns or very young infants. It parallels many potentially human infections, such as measles, rubella, polio. In this section, we propose a SVIR model in which a continuous vaccination strategy is considered, and a proportion of the newborn p ( 0 1 p ≤ ≤ ) was by default vaccinated. We also assume that the permanent immunity acquired through vaccination is the same as the natural immunity obtained from infected individuals eliminating the disease naturally.
The mathematical model can be described as: 
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, and the meanings of other model parameters and the schematic diagram of model (1) see Table 1 and Figure 1 , respectively.
The initial condition of model (1) is given as Assuming that the vaccine is perfect, which means that it confers life-long protection. For model (1), we can get two nontrivial disease-free equilibria and a endemic equilibrium. That is, the disease-free equilibrium without mosquitoes 
Stability of Equilibria
Firstly, on the globally asymptotical stability of disease-free equilibrium without mosquito 01 E , we have the following theorem. 
Obviously, it is easy to obtain that system (6) has a unique positive equilibrium ( ) ( ) 
It is easy to obtain that ( ) 0 y t * = is the solution of (7) for small enough  , which is globally asymptotically stable. On the stability of disease-free equilibrium with mosquitoes, linearizing model (1) about 02 E yields the characteristic equation 
Obviously, the study of solving these transcendental equations of (8) and (9) 
it is obvious that the equilibrium ( ) 0, 0 always exists. Linearizing the model (11) about ( ) 0, 0 yields the characteristic equation 
Optimal Vaccination
In this section, the vaccination of model (1) is seen as a control variable to reduce or even eradicate the disease. Let p be the control variable: 
where D γ and V γ representing the weights of the costs of treatment of infected people and vaccination, respectively, and they are both positive constants. We solve the problem using optimal control theory. Consider the set of admissible control functions
We have the following theorem on the existence of optimal vaccination. Theorem 4. The problem (1) and (13) with the initial condition (2) , admits a unique optimal solution 
and the transversality conditions
max 0, min 1,
Proof. The existence of optimal solution are both having positive stable states (see Figure 4 (b)). As for the numbers of infectious individuals, although the numbers are not too many, there is a positive stable state in Figure 4 (a) if the figure is amplified. That is to say, the existence of positive equilibrium are confirmed and the positive equilibrium is likely to locally asymptotically stable for 01 1 >  and 02 1 τ >  . Of course, this conclusion also needs further confirm, don't make discussion in this paper. pace with increasing of the value of τ , the number of mosquitoes are decreasing, that is to say, the bigger the value of τ , the few the number of mosquitoes; the bigger the value of τ , the better the effect of controlling the virus of dengue. To study the effects of the vertical transmission rate q, make 5 τ = , 0.01 p = and other parameters are fixed as above ( Figure 5(b) ). Obviously, for a bigger value q, the only peak of explosion of h I or m I is bigger, that is, the number of infectious individuals or mosquitoes are 
Fund
This work was supported in part by the Natural Science Foundation of Xinjiang (Grant No. 2016D01C046).
